Reuters logo
BRIEF-Merrimack announces completion of enrollment in phase 2 carrie study of mm-141
June 19, 2017 / 11:22 AM / 6 months ago

BRIEF-Merrimack announces completion of enrollment in phase 2 carrie study of mm-141

June 19 (Reuters) - Merrimack Pharmaceuticals Inc

* Merrimack announces completion of enrollment in phase 2 carrie study of mm-141; data expected in first half of 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below